Is Tilray the Best Value Play in the $7.4 Billion Cannabis Beverage Market?
Although cannabis stocks have not performed well over the past five years, there is still some hope left for the industry. According to some projections, the market will continue …
Why Tilray’s Marijuana Rescheduling Sizzle Has Fizzled
Rescheduling does matter greatly. Moving from Schedule I to Schedule III takes marijuana out of the same league as heroin, and places it in the same ca …
Cannabis ETFs: Regulatory Momentum Returns Focus
Cannabis stocks often trade less on traditional fundamentals alone and more on changes in policy. Cannabis ETFs are a narrow but differentiated thematic play on potential regulatory upside.
Forget SNDL: HITI is a Significantly Better Cannabis Stock
Every cannabis trader’s feed is buzzing about SNDL (NASDAQ:SNDL) because the company’s Q1 2026 release on April 28, 2026 delivered a tidy little EPS beat that retail can rally around. The underlying …
Prediction: Green Thumb Industries Stock Will Double Within 3 Years
Green Thumb is about as blue chip as it comes in the U.S. cannabis industry. The company has multiple potential catalysts that could drive its stock higher. One knock against Green Thumb, though, is …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Why Tilray’s Marijuana Rescheduling Sizzle Has Fizzled
Rescheduling does matter greatly. Moving from Schedule I to Schedule III takes marijuana out of the same league as heroin, and places it in the same ca …
Cannabis ETFs: Regulatory Momentum Returns Focus
Cannabis stocks often trade less on traditional fundamentals alone and more on changes in policy. Cannabis ETFs are a narrow but differentiated thematic play on potential regulatory upside.
Forget SNDL: HITI is a Significantly Better Cannabis Stock
Every cannabis trader’s feed is buzzing about SNDL (NASDAQ:SNDL) because the company’s Q1 2026 release on April 28, 2026 delivered a tidy little EPS beat that retail can rally around. The underlying …
Prediction: Green Thumb Industries Stock Will Double Within 3 Years
Green Thumb is about as blue chip as it comes in the U.S. cannabis industry. The company has multiple potential catalysts that could drive its stock higher. One knock against Green Thumb, though, is …
Tilray and other pot stocks soar as Trump is reportedly ready to reclassify cannabis
The move, which could open up medical research on cannabis as well as banking services for growers, follows an executive order to reclassify the substance in December.
Tilray Brands (TLRY) Price Forecast: Cannabis Rescheduling Fuels Recovery
Trend Identification & Analysis: How to Read the Market’s Footprints Before the Crowd Does Cannabis-related stocks and ETFs have been among the worst-performing groups in recent years. A peak was …
MSOS: Trump’s Green Light – Why Cannabis Stocks Are Surging On Rescheduling News (Rating Upgrade)
MSOS is upgraded to Buy ahead of US cannabis rescheduling catalysts—Schedule III could end 280E taxes, boost MSO profits, and drive re-ratings. Read more here.
Why are cannabis stocks surging today?
Shares of major cannabis companies rallied sharply on Wednesday after reports suggested the Trump Administration could soon move to reclassify marijuana, a long-awaited step that investors believe …
Canadian Cannabis Stocks Jump on Report U.S. May Move to Reclassify Marijuana
Canadian cannabis companies surged Wednesday after an Axios report said that the Trump Administration could move to reclassify marijuana.
Recent Comments